Recent extremely meaningful positive changes in fundamentals have benefitted Fresenius Medical Care AG &Co KG (NYSE: FMS): the consensus estimate for December, 2024 increased significantly, the stock’s power rating rose above 70, the consensus estimate for December, 2025 increased significantly, and significant quarterly earnings acceleration occurred.
In light of these very positive signals we are reviewing our current Overall Rating of A. We would continue to view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
Fresenius Medical Care AG &Co KG has a current Value Trend Rating of A (Highest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Fresenius Medical Care AG &Co KG has a good Power Rating of 72 and a good Appreciation Score of 82, and the Highest Value Trend Rating results.
Recent Price Action
On 2/7/25, Fresenius Medical Care AG &Co KG (NYSE: FMS) stock rose slightly by 0.2%, closing at $24.35. This advance was accompanied by normal trading volume. Relative to the market the stock has been strong over the last nine months but has declined -2.4% during the last week.
Be the first to comment